Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01-GM090278)
Howard Hughes Medical Institute
Received: 27 March 2019
Accepted: 27 May 2019
First Online: 3 July 2019
: J.T.L. is a co-founder of and a scientific advisor for Translate Bio and Fulcrum Therapeutics. The other authors declare no competing interests.